India, Nov. 28 -- image credit- shutterstock

The vaccines market reached Rs 2,217.28 crore in MAT October 2025, registering a strong 12% growth. Human Normal Immunoglobulin led the segment at Rs 279.38 crore with 12% growth, followed by Anti-Rabies Vaccine at Rs 263.67 crore (+15%) and Influenza Vaccine at Rs 253.79 crore (+14%), according to Sheetal Sapale, Vice President - Commercial at Pharmarack Technologies.

Combination vaccines with tetanus components grew 20% to Rs 199.88 crore, while pneumonia vaccines rose 14% to Rs 171.13 crore. Meningococcal vaccines delivered a robust 24% increase, reaching Rs 146.84 crore.

Sheetal Sapale noted impressive surges in Typhoid and Paratyphoid vaccines, which jumped 49% to Rs 72.01 crore, Japane...